SEARCH

SEARCH BY CITATION

References

  • 1
    Espey D,Wu X,Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007; 110: 2119-2152.
  • 2
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, Ga: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2007.
  • 3
    Jackson-Thompson J,Ahmed F,German R,Lai S,Friedman C. Descriptive epidemiology of colorectal cancer in the United States, 1998-2001. Cancer. 2006; 107( 5 suppl): 1103-1111.
  • 4
    Hardcastle J,Chamberlain J,Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
  • 5
    Kronborg O,Fenger C,Olsen J,Jorgensen O,Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348: 1467-1471.
  • 6
    Mandel J,Bond J,Church T, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993; 328: 1365-1371.
  • 7
    Mandel J,Church T,Bond J, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343: 1603-1607.
  • 8
    Newcomb P,Norfleet R,Storer B,Surawicz T,Marcus P. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992; 84: 1572-1575.
  • 9
    Selby J,Friedman G,Quesenberry C,Weiss N. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992; 326: 653-657.
  • 10
    Smith R,Cokkinides V,Eyre H. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006; 56: 11-25.
  • 11
    U.S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med. 2002; 137: 129-131.
  • 12
    Winawer S,Fletcher R,Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale—update based on new evidence. Gastroenterology. 2003; 124: 544-560.
  • 13
    Agrawal S,Bhupinderjit A,Bhutani M, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005; 100: 515-523.
    Direct Link:
  • 14
    National Cancer Institute Surveillance Research Program. Surveillance, Epidemiology, and End Result (SEER). Bethesda, Md: National Cancer Institute; 2007. Available at: www.seer.cancer.gov. Accessed on June 26, 2008.
  • 15
    Thoburn K,German R,Lewis M,Nichols P,Ahmed F,Jackson-Thompson J. Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer. 2007: 109; 1607-1016.
  • 16
    North American Association of Central Cancer Registries (NAACCR). NAACCR Data Standards for Cancer Registries. Springfield, Ill: NAACCR; 2008; Available at: http://www.naaccr.org. Accessed on June 26, 2008.
  • 17
    Wu X,Chen V,Martin J, et al. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1215-1222.
  • 18
    Young JJ, Roffers S, Ries L, Fritz A, Hurlbut A, eds. SEER Summary Staging Manual-2000: Codes and Coding Instructions. NIH Publication No. 01-4969. Bethesda, Md: National Cancer Institute; 2001.
  • 19
    Tiwari R,Clegg L,Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006; 15: 547-569.
  • 20
    Chu KC,Miller B,Springfield S. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc. 2007; 99: 1092-1104.
  • 21
    Harper S,Lynch J,Meersman S,Breen N,Davis W,Reichman M. An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992-2004. Am J Epidemiol. 2008; 167: 889-899.
  • 22
    Keppel K,Pamuk E,Lynch J, et al. Methodological Issues in Measuring Health Disparities. Report No. 141. Hyattsville, Md: National Center for Health Statistics; 2005.
  • 23
    Harper S,Lynch J. Methods for Measuring Cancer Disparities: Using Data Relevant to Healthy People 2010 Cancer-Related Objectives. NCI Cancer Surveillance Monograph Series, No. 6. NIH Publication 05-5777. Bethesda, Md: National Cancer Institute; 2005.
  • 24
    Keppel KG. Ten largest racial and ethnic health disparities in the United States based on Healthy People 2010 Objectives. Am J Epidemiol. 2007; 166: 97-103.
  • 25
    Chu K,Tarone R,Chow W,Alexander G. Colorectal cancer trends by race and anatomic subsites, 1975 to 1991. Arch Fam Med. 1995; 4: 849-856.
  • 26
    Fairley T,Cardinez C,Martin J, et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer. 2006; 107( 5 suppl): 1153-1161.
  • 27
    Irby K,Anderson W,Henson D,Devesa S. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev. 2006; 15: 792-797.
  • 28
    Jemal A,Siegel R,Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
  • 29
    Matanoski G,Tao X,Almon L,Adade A,Davies-Cole J. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer. 2006; 107( 5 suppl): 1112-1120.
  • 30
    Weir H,Thun M,Hankey B, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003; 95: 1276-1299.
  • 31
    Ahmed R,Schmitz K,Anderson K,Rosamond W,Folsom A. The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006; 107: 28-36.
  • 32
    Coughlin S,Thompson T. Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health. 2004; 20: 118-124.
  • 33
    Koroukian SM,Xu F,Dor A,Cooper GS. Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status. Health Serv Res. 2006; 41: 2136-2154.
  • 34
    Kupfer SS,McCaffrey S,Kim KE. Racial and gender disparities in hereditary colorectal cancer risk assessment: the role of family history. J Cancer Educ. 2006; 21( 1 suppl): S32-S36.
  • 35
    Lai S,Zhang K,Uhler R,Harrison J,Clutter G,Williams M. Geographic variation in the incidence of colorectal cancer in the United States, 1998-2001. Cancer. 2006; 107( 5 suppl): 1172-1180.
  • 36
    McCollum A,Catalano P,Haller D, et al. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst. 2002; 94: 1160-1167.
  • 37
    Seeff L,Nadel M,Klabunde C, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004; 100: 2093-2103.
  • 38
    Greiner K,Engelman K,Hall M,Ellerbeck E. Barriers to colorectal cancer screening in rural primary care. Prev Med. 2004; 38: 269-275.
  • 39
    Ward E,Halpern M,Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008; 58: 9-31.
  • 40
    Giovannucci E,Wu K. Cancers of the colon and rectum. In: Schottenfeld D, Fraumeni J, eds. Cancer Epidemiology and Prevention.3rd ed. New York, NY: Oxford University Press; 2006: 809-829.
  • 41
    Chien C,Morimoto L,Tom J,Li C. Differences in colorectal carcinoma stage and survival by race and ethnicity. Cancer. 2005; 104: 629-639.
  • 42
    Kauh J,Brawley O,Berger M. Racial disparities in colorectal cancer. Curr Probl Cancer. 2007; 31: 123-133.
  • 43
    Coughlin S,Thompson T. Physician recommendation for colorectal cancer screening by race, ethnicity, and health insurance status among men and women in the United States, 2000. Health Promot Pract. 2005; 6: 369-378.
  • 44
    Centers for Disease Control and Prevention. Use of colorectal cancer tests—United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep. 2008; 57: 253-258.
  • 45
    Levin B,Leiberman D,McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008; 58: 130-160.
  • 46
    U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 627-637.
  • 47
    American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 384 November 2007: colonoscopy and colorectal cancer screening and prevention. Obstet Gynecol. 2007; 110: 1199-1202.
  • 48
    Zauber A,Lansdorp-Vogelaar I,Wilschut J,Knudsen A,van Ballegooijen M,Kuntz K. Technology Assessments for Cost-Effectiveness of DNA Stool Test to Screen for Colorectal Cancer. Washington, DC: Department of Health and Human Services, Centers for Medicare & Medicaid Services; 2007. Available at: http://www.cms.hhs.gov/mcd/viewtechassess.asp?from2=viewtechassess.asp&id=212& Accessed on October 19, 2008.
  • 49
    Rockhill B,Kawachi I,Colditz G. Individual risk prediction and population-wide disease prevention. Epidemiol Rev. 2000; 22: 176-180.